Biotech Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Notifies Eiger BioPharmaceuticals, Inc. (EIGR) Investors of Class Action and Encourages Investors to Actively Participate December 2, 2022
Biotech EIGR SHAREHOLDER ALERT: Jakubowitz Law Reminds Eiger Shareholders of a Lead Plaintiff Deadline of January 9, 2023 December 2, 2022
Biotech ANAVEX®2-73 (Blarcamesine) Phase 2B/3 Study Met Primary and Key Secondary Endpoints, Showing Statistically Significant Reduction of Clinical Decline in Global Clinical Study of Patients With Early Alzheimer’s Disease December 1, 2022
Biotech Affimed to Host Investor Event Highlighting AFM13 Clinical Development at 2022 ASH Annual Meeting December 1, 2022
Biotech Cocrystal Pharma Highlights Progress with CC-42344 as a Potential Oral Treatment for Pandemic and Seasonal Influenza A at the World Antiviral Congress 2022 December 1, 2022
Biotech SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EQ, MTCR, TALO, SSNT December 1, 2022